Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Cytochrome P450-isoenzyme 1A1 in susceptibility to tobacco-related lung cancer.

El Sadeck N, Ibrahim BM, Alassal MA.

Asian Cardiovasc Thorac Ann. 2014 Mar;22(3):315-8. doi: 10.1177/0218492313492987.

PMID:
24585908
2.

A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States)

Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC.

Cancer Causes Control. 1997 Jul;8(4):544-53. Erratum in: Cancer Causes Control 1998 Jan;9(1):126.

PMID:
9242469
3.
4.

Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.

Bennett WP, Alavanja MC, Blomeke B, Vähäkangas KH, Castrén K, Welsh JA, Bowman ED, Khan MA, Flieder DB, Harris CC.

J Natl Cancer Inst. 1999 Dec 1;91(23):2009-14.

5.

Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.

Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D.

Mutat Res. 2008 Mar 1;639(1-2):1-10.

PMID:
18082227
6.

Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5.

Wang HW, Chen TL, Yang PC, Ueng TH.

Drug Metab Dispos. 2001 Sep;29(9):1229-35.

7.

Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.

Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):687-92.

8.

Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.

Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.

Cancer Res. 1998 Feb 15;58(4):667-71.

9.

Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.

Anttila S, Vainio H, Hietanen E, Camus AM, Malaveille C, Brun G, Husgafvel-Pursiainen K, Heikkilä L, Karjalainen A, Bartsch H.

Environ Health Perspect. 1992 Nov;98:179-82.

10.
11.

Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.

Bartsch H, Castegnaro M, Rojas M, Camus AM, Alexandrov K, Lang M.

Toxicol Lett. 1992 Dec;64-65 Spec No:477-83.

PMID:
1471200
12.

Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.

Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ.

Br J Cancer. 1999 May;80(3-4):598-603.

13.

Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.

Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R.

J Hum Genet. 2005;50(12):618-27.

PMID:
16228113
14.

Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).

McGrath M, Hankinson SE, De Vivo I.

Cancer Causes Control. 2007 Dec;18(10):1123-30.

PMID:
17717632
15.

Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1.

Katiyar SK, Matsui MS, Mukhtar H.

J Invest Dermatol. 2000 Feb;114(2):328-33.

16.

Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.

Kim JH, Sherman ME, Curriero FC, Guengerich FP, Strickland PT, Sutter TR.

Toxicol Appl Pharmacol. 2004 Sep 15;199(3):210-9.

PMID:
15364538
17.

Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.

Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1075-80.

18.

Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.

Villard PH, Seree EM, Re JL, De Meo M, Barra Y, Attolini L, Dumenil G, Catalin J, Durand A, Lacarelle B.

Toxicol Appl Pharmacol. 1998 Feb;148(2):195-204.

PMID:
9473526
19.

The role of CYP1A1 Msp1 gene polymorphisms on lung cancer development in Turkey.

Demir A, Altin S, Demir I, Köksal V, Cetinçelik U, Dinçer I.

Tuberk Toraks. 2005;53(1):5-9.

PMID:
15765281
20.

Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.

Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, Schuermann WH, Thilly WG, Olson DE, Hammersley JR, Crespi CL, Utell MJ.

Am J Respir Cell Mol Biol. 1997 Jul;17(1):114-24.

PMID:
9224217
Items per page

Supplemental Content

Support Center